This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Baseline α-synuclein seeding activity and disease progression in sporadic and genetic Parkinson’s disease in the PPMI cohort
Output Details
Preprint October 10, 2024
Description
**Background** α-Synuclein (α-syn) seed amplification assays (SAAs) have shown remarkable potential in diagnosing Parkinson's disease (PD). Using data from the Parkinson's Progression Markers Initiative (PPMI) cohort, we aimed to test whether baseline α-syn seeding activity was associated with disease progression in sporadic PD, *LRRK2*-associated PD (*LRRK2* PD), and *GBA*-associated PD (*GBA* PD).
**Methods** We analyzed 7 years of motor, non-motor, and cognitive assessments and 5 years of dopamine transporter imaging along with baseline α-syn SAA results from 564 PPMI participants (n=332 sporadic PD, 162 *LRRK2* PD, and 70 *GBA* PD) using linear mixed-effects models, adjusted for potential confounders, to test whether baseline α-syn SAA positivity (n=315 sporadic PD, 111 *LRRK2* PD, and 66 *GBA* PD) was associated with PD progression.
**Results** While non-statistically significant, there was a trend towards faster motor decline in participants with α-syn SAA positive *LRRK2* PD compared to those with α-syn SAA negative *LRRK2* PD (MDS-UPDRS III points per year: 2.39 (95% confidence interval: 1.86 – 2.92) vs. 1.76 (0.93 – 2.60); difference=0.63 (-0.29 – 1.55, p=0.18). There was no difference in motor decline between α-syn SAA positive and α-syn SAA negative participants with sporadic PD (2.46 (2.20 – 2.72) vs. 2.39 (1.36 – 3.42); difference=0.07 (-0.99 – 1.12), p=0.90) or *GBA* PD (2.67 (1.91 – 3.44) vs. 2.40 (-0.18 – 4.99); difference=0.27 (-2.42 – 2.96), p=0.84). No statistically significant differences were seen in the progression of non-motor symptoms, cognition, or DAT imaging.
**Conclusions** We found no statistically significant associations between baseline α-syn seeding activity and PD progression among manifest patients in the PPMI cohort. Future studies are needed to further investigate relationships among baseline α-syn seeding activity, disease heterogeneity, disease stage, and PD progression.
Identifier (DOI)
10.1101/2024.09.27.24311107